ZA200204054B - Combination of n-phenyl-n-benzoyl urea derivative and nectin compounds for parasite control. - Google Patents

Combination of n-phenyl-n-benzoyl urea derivative and nectin compounds for parasite control. Download PDF

Info

Publication number: ZA200204054B
Authority: ZA; South Africa
Prior art keywords: combination; active ingredient; endoparasites; pets; ecto
Prior art date: 1999-11-25

Application number

ZA200204054A

Other languages

English (en)

Inventor

Jacques Bouvier

Catherine Kolly

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-25

Filing date

2002-05-22

Publication date

2002-11-22

2002-05-22 Application filed by Novartis Ag filed Critical Novartis Ag

2002-11-22 Publication of ZA200204054B publication Critical patent/ZA200204054B/en

Links

150000001875 compounds Chemical class 0.000 title claims description 21
244000045947 parasite Species 0.000 title claims description 15
102000002356 Nectin Human genes 0.000 title 1
108060005251 Nectin Proteins 0.000 title 1
239000004480 active ingredient Substances 0.000 claims description 59
241001465754 Metazoa Species 0.000 claims description 56
238000002360 preparation method Methods 0.000 claims description 35
239000000203 mixture Substances 0.000 claims description 30
241000238876 Acari Species 0.000 claims description 28
229910052739 hydrogen Inorganic materials 0.000 claims description 28
244000079386 endoparasite Species 0.000 claims description 11
244000144972 livestock Species 0.000 claims description 11
AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims description 10
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims description 10
239000001257 hydrogen Substances 0.000 claims description 10
229960002418 ivermectin Drugs 0.000 claims description 10
QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 claims description 9
229960003997 doramectin Drugs 0.000 claims description 9
125000004429 atom Chemical group 0.000 claims description 8
YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 claims description 8
229960004816 moxidectin Drugs 0.000 claims description 8
241000244206 Nematoda Species 0.000 claims description 7
239000003814 drug Substances 0.000 claims description 7
150000003839 salts Chemical class 0.000 claims description 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
YOWNVPAUWYHLQX-UHFFFAOYSA-N fluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C(OC=2C(=CC(=CN=2)C(F)(F)F)Cl)=C1 YOWNVPAUWYHLQX-UHFFFAOYSA-N 0.000 claims description 5
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
238000000034 method Methods 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
230000009885 systemic effect Effects 0.000 claims 2
230000000694 effects Effects 0.000 description 30
239000007943 implant Substances 0.000 description 16
239000013543 active substance Substances 0.000 description 14
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 13
239000003826 tablet Substances 0.000 description 13
229920002472 Starch Polymers 0.000 description 11
238000009472 formulation Methods 0.000 description 10
235000019698 starch Nutrition 0.000 description 10
239000000126 substance Substances 0.000 description 10
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 9
239000008101 lactose Substances 0.000 description 9
238000012360 testing method Methods 0.000 description 9
RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical class C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 8
235000013305 food Nutrition 0.000 description 8
239000008107 starch Substances 0.000 description 8
239000000454 talc Substances 0.000 description 8
229910052623 talc Inorganic materials 0.000 description 8
235000012222 talc Nutrition 0.000 description 8
201000010099 disease Diseases 0.000 description 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
235000013601 eggs Nutrition 0.000 description 7
235000019359 magnesium stearate Nutrition 0.000 description 7
239000000725 suspension Substances 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
239000005660 Abamectin Substances 0.000 description 6
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
241001481694 Dermanyssus Species 0.000 description 6
108010010803 Gelatin Proteins 0.000 description 6
239000008280 blood Substances 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
239000000460 chlorine Substances 0.000 description 6
244000078703 ectoparasite Species 0.000 description 6
239000008273 gelatin Substances 0.000 description 6
229920000159 gelatin Polymers 0.000 description 6
229940014259 gelatin Drugs 0.000 description 6
235000019322 gelatine Nutrition 0.000 description 6
235000011852 gelatine desserts Nutrition 0.000 description 6
238000011282 treatment Methods 0.000 description 6
206010061217 Infestation Diseases 0.000 description 5
HRYILSDLIGTCOP-UHFFFAOYSA-N N-benzoylurea Chemical compound NC(=O)NC(=O)C1=CC=CC=C1 HRYILSDLIGTCOP-UHFFFAOYSA-N 0.000 description 5
230000037396 body weight Effects 0.000 description 5
239000002775 capsule Substances 0.000 description 5
239000000839 emulsion Substances 0.000 description 5
239000008187 granular material Substances 0.000 description 5
229920001223 polyethylene glycol Polymers 0.000 description 5
239000007787 solid Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
238000001228 spectrum Methods 0.000 description 5
241001481695 Dermanyssus gallinae Species 0.000 description 4
241001494479 Pecora Species 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
239000007788 liquid Substances 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
229920001592 potato starch Polymers 0.000 description 4
239000002904 solvent Substances 0.000 description 4
241000283690 Bos taurus Species 0.000 description 3
241000282472 Canis lupus familiaris Species 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
241000282326 Felis catus Species 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
208000015336 Helminthic disease Diseases 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
241000238680 Rhipicephalus microplus Species 0.000 description 3
235000021355 Stearic acid Nutrition 0.000 description 3
239000000654 additive Substances 0.000 description 3
150000008047 benzoylureas Chemical class 0.000 description 3
239000000969 carrier Substances 0.000 description 3
238000000576 coating method Methods 0.000 description 3
239000000470 constituent Substances 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
244000000013 helminth Species 0.000 description 3
150000002431 hydrogen Chemical group 0.000 description 3
-1 hydroxyimino Chemical group 0.000 description 3
239000012528 membrane Substances 0.000 description 3
229920000609 methyl cellulose Polymers 0.000 description 3
239000001923 methylcellulose Substances 0.000 description 3
235000010981 methylcellulose Nutrition 0.000 description 3
FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
230000017448 oviposition Effects 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
239000011148 porous material Substances 0.000 description 3
235000013772 propylene glycol Nutrition 0.000 description 3
AFJYYKSVHJGXSN-KAJWKRCWSA-N selamectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C(/C)=C/C[C@@H](O[C@]2(O[C@@H]([C@@H](C)CC2)C2CCCCC2)C2)C[C@@H]2OC(=O)[C@@H]([C@]23O)C=C(C)C(=N\O)/[C@H]3OC\C2=C/C=C/[C@@H]1C AFJYYKSVHJGXSN-KAJWKRCWSA-N 0.000 description 3
229960002245 selamectin Drugs 0.000 description 3
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
235000012239 silicon dioxide Nutrition 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
235000010356 sorbitol Nutrition 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
239000008117 stearic acid Substances 0.000 description 3
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
229910002012 Aerosil® Inorganic materials 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
241001481703 Rhipicephalus <genus> Species 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
241000607479 Yersinia pestis Species 0.000 description 2
239000002313 adhesive film Substances 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
230000002411 adverse Effects 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
239000007900 aqueous suspension Substances 0.000 description 2
235000019445 benzyl alcohol Nutrition 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
229940075614 colloidal silicon dioxide Drugs 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
230000003467 diminishing effect Effects 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000000945 filler Substances 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
229950006719 fluazuron Drugs 0.000 description 2
239000011521 glass Substances 0.000 description 2
229940074076 glycerol formal Drugs 0.000 description 2
239000007902 hard capsule Substances 0.000 description 2
230000012447 hatching Effects 0.000 description 2
244000144980 herd Species 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
150000002678 macrocyclic compounds Chemical class 0.000 description 2
239000000463 material Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
239000003921 oil Substances 0.000 description 2
235000019198 oils Nutrition 0.000 description 2
244000052769 pathogen Species 0.000 description 2
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
239000008159 sesame oil Substances 0.000 description 2
235000011803 sesame oil Nutrition 0.000 description 2
241000894007 species Species 0.000 description 2
238000003756 stirring Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
229940100445 wheat starch Drugs 0.000 description 2
ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Polymers FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
BOHGAOWOIJMTPZ-UHFFFAOYSA-N 1,3-dioxolan-4-ylmethanol Chemical compound OCC1COCO1 BOHGAOWOIJMTPZ-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
PKTIFYGCWCQRSX-UHFFFAOYSA-N 4,6-diamino-2-(cyclopropylamino)pyrimidine-5-carbonitrile Chemical compound NC1=C(C#N)C(N)=NC(NC2CC2)=N1 PKTIFYGCWCQRSX-UHFFFAOYSA-N 0.000 description 1
IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000238679 Amblyomma Species 0.000 description 1
241001147657 Ancylostoma Species 0.000 description 1
241001147672 Ancylostoma caninum Species 0.000 description 1
241000244186 Ascaris Species 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
241000893172 Chabertia Species 0.000 description 1
235000008733 Citrus aurantifolia Nutrition 0.000 description 1
208000003322 Coinfection Diseases 0.000 description 1
241000694440 Colpidium aqueous Species 0.000 description 1
241001126268 Cooperia Species 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
241001480824 Dermacentor Species 0.000 description 1
241001147667 Dictyocaulus Species 0.000 description 1
241000243990 Dirofilaria Species 0.000 description 1
241000243988 Dirofilaria immitis Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
241000243976 Haemonchus Species 0.000 description 1
241000243974 Haemonchus contortus Species 0.000 description 1
241000920462 Heterakis Species 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
241001480803 Hyalomma Species 0.000 description 1
241000238681 Ixodes Species 0.000 description 1
239000005912 Lufenuron Substances 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
241000002163 Mesapamea fractilinea Species 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
208000031888 Mycoses Diseases 0.000 description 1
241001137882 Nematodirus Species 0.000 description 1
241000819999 Nymphes Species 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
241000243795 Ostertagia Species 0.000 description 1
241000904715 Oxyuris Species 0.000 description 1
239000005662 Paraffin oil Substances 0.000 description 1
241000244187 Parascaris Species 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
206010035148 Plague Diseases 0.000 description 1
241001480837 Rhipicephalus annulatus Species 0.000 description 1
241000606651 Rickettsiales Species 0.000 description 1
241000232199 Setariidae Species 0.000 description 1
241000244174 Strongyloides Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
235000011941 Tilia x europaea Nutrition 0.000 description 1
241000607216 Toxascaris Species 0.000 description 1
241000244031 Toxocara Species 0.000 description 1
241000244030 Toxocara canis Species 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
241000243797 Trichostrongylus Species 0.000 description 1
241001489151 Trichuris Species 0.000 description 1
241001638368 Trichuris vulpis Species 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
241000571986 Uncinaria Species 0.000 description 1
SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
229950008167 abamectin Drugs 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
230000000895 acaricidal effect Effects 0.000 description 1
239000000642 acaricide Substances 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
229940081735 acetylcellulose Drugs 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
239000003674 animal food additive Substances 0.000 description 1
230000000507 anthelmentic effect Effects 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
NJTGMYOUKBELLQ-NVQQORPBSA-N avermectin b1 monosaccharide Chemical compound O1C(C)C(O)C(OC)CC1O[C@@H]1C(/C)=C/C[C@@H](O[C@]2(C3)C=C[C@H](C)[C@@H](C(C)C)O2)C[C@@H]3OC(=O)[C@@H]([C@]23O)C=C(C)[C@@H](O)[C@H]3OC\C2=C/C=C/[C@@H]1C NJTGMYOUKBELLQ-NVQQORPBSA-N 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000006399 behavior Effects 0.000 description 1
235000015895 biscuits Nutrition 0.000 description 1
238000009835 boiling Methods 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
235000013539 calcium stearate Nutrition 0.000 description 1
239000008116 calcium stearate Substances 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
150000001733 carboxylic acid esters Chemical class 0.000 description 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
235000015111 chews Nutrition 0.000 description 1
UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
238000001816 cooling Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
BSBSDQUZDZXGFN-UHFFFAOYSA-N cythioate Chemical compound COP(=S)(OC)OC1=CC=C(S(N)(=O)=O)C=C1 BSBSDQUZDZXGFN-UHFFFAOYSA-N 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000006735 deficit Effects 0.000 description 1
239000007857 degradation product Substances 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000019700 dicalcium phosphate Nutrition 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
235000013681 dietary sucrose Nutrition 0.000 description 1
229940099686 dirofilaria immitis Drugs 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
235000006694 eating habits Nutrition 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
230000001793 endectocide Effects 0.000 description 1
239000002702 enteric coating Substances 0.000 description 1
238000009505 enteric coating Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000010685 fatty oil Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
239000006260 foam Substances 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229920006158 high molecular weight polymer Polymers 0.000 description 1
FYQGBXGJFWXIPP-UHFFFAOYSA-N hydroprene Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 description 1
229930000073 hydroprene Natural products 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000036512 infertility Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000002917 insecticide Substances 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
230000000366 juvenile effect Effects 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
239000004571 lime Substances 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
229960000521 lufenuron Drugs 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000005259 measurement Methods 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229930002897 methoprene Natural products 0.000 description 1
229950003442 methoprene Drugs 0.000 description 1
229960002900 methylcellulose Drugs 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
239000003791 organic solvent mixture Substances 0.000 description 1
230000000590 parasiticidal effect Effects 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000049 pigment Substances 0.000 description 1
239000012165 plant wax Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
239000008389 polyethoxylated castor oil Substances 0.000 description 1
229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229940116317 potato starch Drugs 0.000 description 1
239000004540 pour-on Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000019617 pupation Effects 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
229940100486 rice starch Drugs 0.000 description 1
230000001932 seasonal effect Effects 0.000 description 1
238000010517 secondary reaction Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
235000002639 sodium chloride Nutrition 0.000 description 1
239000007901 soft capsule Substances 0.000 description 1
239000012439 solid excipient Substances 0.000 description 1
RNVYQYLELCKWAN-UHFFFAOYSA-N solketal Chemical compound CC1(C)OCC(CO)O1 RNVYQYLELCKWAN-UHFFFAOYSA-N 0.000 description 1
239000004544 spot-on Substances 0.000 description 1
238000011146 sterile filtration Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
229960004793 sucrose Drugs 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
239000002700 tablet coating Substances 0.000 description 1
238000009492 tablet coating Methods 0.000 description 1
201000001064 tick infestation Diseases 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
235000010487 tragacanth Nutrition 0.000 description 1
239000000196 tragacanth Substances 0.000 description 1
229940116362 tragacanth Drugs 0.000 description 1
238000012546 transfer Methods 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
229940078499 tricalcium phosphate Drugs 0.000 description 1
235000019731 tricalcium phosphate Nutrition 0.000 description 1
229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
239000013598 vector Substances 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
- A01N47/34—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the groups, e.g. biuret; Thio analogues thereof; Urea-aldehyde condensation products
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Dentistry (AREA)
Tropical Medicine & Parasitology (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200204054A 1999-11-25 2002-05-22 Combination of n-phenyl-n-benzoyl urea derivative and nectin compounds for parasite control. ZA200204054B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99811085A EP1103181A1 (de)	1999-11-25	1999-11-25	Kombination der N-Phenyl-N'-Benzoyl Harnstoff Derivaten und Avermectin für Parasiten Kontrolle.

Publications (1)

Publication Number	Publication Date
ZA200204054B true ZA200204054B (en)	2002-11-22

Family

ID=8243160

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200204054A ZA200204054B (en)	1999-11-25	2002-05-22	Combination of n-phenyl-n-benzoyl urea derivative and nectin compounds for parasite control.

Country Status (21)

Country	Link
US (1)	US6469067B1 (pt)
EP (2)	EP1103181A1 (pt)
JP (1)	JP2003514834A (pt)
KR (1)	KR100444710B1 (pt)
CN (1)	CN1227977C (pt)
AR (1)	AR026596A1 (pt)
AT (1)	ATE286657T1 (pt)
AU (1)	AU772116B2 (pt)
BR (1)	BR0015815A (pt)
CA (1)	CA2390724A1 (pt)
CO (1)	CO5251430A1 (pt)
DE (1)	DE60017465T2 (pt)
DK (1)	DK1244359T3 (pt)
ES (1)	ES2236015T3 (pt)
MX (1)	MXPA02005245A (pt)
NZ (1)	NZ518754A (pt)
PT (1)	PT1244359E (pt)
RU (1)	RU2258367C2 (pt)
TW (1)	TWI264288B (pt)
WO (1)	WO2001037667A1 (pt)
ZA (1)	ZA200204054B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2561348A1 (en) *	2004-04-07	2005-10-27	Intervet International B.V.	Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
KR101538599B1 (ko)	2006-07-28	2015-07-21	인터벳 인터내셔널 비.브이.	마크롤라이드 합성 방법
KR100788620B1 (ko) *	2006-12-12	2007-12-26	주식회사 대우아이에스	카오디오
BG1461U1 (bg) *	2011-03-18	2011-07-29	"Ендектовет" Еоод	Състави за противопаразитно лекарствено средство
CN104334159A (zh)	2012-04-04	2015-02-04	英特维特国际股份有限公司	异噁唑啉化合物的固体口服药物组合物
BR112018071835A2 (pt) *	2016-04-25	2019-02-19	Can Technologies, Inc.	método para preparar uma mistura de ração para animal, método de embalagem de um microingrediente e recipiente da ração para animal solúvel
AU2018292285B2 (en)	2017-06-26	2023-05-25	Boehringer Ingelheim Animal Health USA Inc.	Dual active parasiticidal granule compositions, methods and uses thereof
AU2019264965A1 (en)	2018-05-09	2020-11-19	Nectin Therapeutics Ltd.	Antibodies specific to human Nectin4
EP3943074A1 (en) *	2020-07-23	2022-01-26	Chemo Research SL	Oral unit dosage form of ivermectin
KR102492381B1 (ko) *	2020-10-08	2023-02-06	대한민국	닭 진드기 방제용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2054962T3 (es)	1986-01-25	1994-08-16	Hoechst Ag	Agentes plaguicidas.
US5192546A (en) *	1991-01-15	1993-03-09	Mycogen Corporation	Synergistic pesticidal compositions
DE4336307A1 (de) *	1993-10-25	1995-04-27	Bayer Ag	Substituiertes Pyrazolinderivat
AU695656B2 (en) *	1995-02-24	1998-08-20	Novartis Tiergesundheit Ag	Composition for controlling parasites

1999
- 1999-11-25 EP EP99811085A patent/EP1103181A1/de not_active Withdrawn
2000
- 2000-09-11 TW TW089118606A patent/TWI264288B/zh not_active IP Right Cessation
- 2000-10-18 CO CO00079305A patent/CO5251430A1/es not_active Application Discontinuation
- 2000-11-20 US US09/718,115 patent/US6469067B1/en not_active Expired - Fee Related
- 2000-11-23 CA CA002390724A patent/CA2390724A1/en not_active Abandoned
- 2000-11-23 AU AU21619/01A patent/AU772116B2/en not_active Expired
- 2000-11-23 AT AT00985086T patent/ATE286657T1/de not_active IP Right Cessation
- 2000-11-23 BR BR0015815-1A patent/BR0015815A/pt not_active Application Discontinuation
- 2000-11-23 CN CNB008162484A patent/CN1227977C/zh not_active Expired - Fee Related
- 2000-11-23 JP JP2001539296A patent/JP2003514834A/ja not_active Withdrawn
- 2000-11-23 AR ARP000106198A patent/AR026596A1/es not_active Application Discontinuation
- 2000-11-23 DE DE60017465T patent/DE60017465T2/de not_active Expired - Fee Related
- 2000-11-23 NZ NZ518754A patent/NZ518754A/en not_active IP Right Cessation
- 2000-11-23 WO PCT/EP2000/011685 patent/WO2001037667A1/en active IP Right Grant
- 2000-11-23 PT PT00985086T patent/PT1244359E/pt unknown
- 2000-11-23 ES ES00985086T patent/ES2236015T3/es not_active Expired - Lifetime
- 2000-11-23 MX MXPA02005245A patent/MXPA02005245A/es active IP Right Grant
- 2000-11-23 KR KR10-2002-7006685A patent/KR100444710B1/ko not_active IP Right Cessation
- 2000-11-23 RU RU2002116223/15A patent/RU2258367C2/ru not_active IP Right Cessation
- 2000-11-23 DK DK00985086T patent/DK1244359T3/da active
- 2000-11-23 EP EP00985086A patent/EP1244359B1/en not_active Expired - Lifetime
2002
- 2002-05-22 ZA ZA200204054A patent/ZA200204054B/en unknown

Also Published As

Publication number	Publication date
JP2003514834A (ja)	2003-04-22
CN1227977C (zh)	2005-11-23
AR026596A1 (es)	2003-02-19
US6469067B1 (en)	2002-10-22
RU2002116223A (ru)	2004-02-27
CA2390724A1 (en)	2001-05-31
WO2001037667A8 (en)	2001-06-28
KR20020059789A (ko)	2002-07-13
KR100444710B1 (ko)	2004-08-16
BR0015815A (pt)	2002-07-30
TWI264288B (en)	2006-10-21
PT1244359E (pt)	2005-05-31
CN1399516A (zh)	2003-02-26
EP1103181A1 (de)	2001-05-30
EP1244359A1 (en)	2002-10-02
CO5251430A1 (es)	2003-02-28
EP1244359B1 (en)	2005-01-12
DE60017465T2 (de)	2005-12-22
RU2258367C2 (ru)	2005-08-20
AU2161901A (en)	2001-06-04
DE60017465D1 (de)	2005-02-17
ES2236015T3 (es)	2005-07-16
ATE286657T1 (de)	2005-01-15
AU772116B2 (en)	2004-04-08
DK1244359T3 (da)	2005-05-09
NZ518754A (en)	2004-02-27
WO2001037667A1 (en)	2001-05-31
MXPA02005245A (es)	2002-11-07

Publication	Publication Date	Title
AU2005294257B2 (en)	2011-05-26	Amitraz compositions
EP1119256B1 (en)	2003-06-04	Oral combination of lufenuron and nitenpyram against fleas
KR100418238B1 (ko)	2004-05-03	기생충 구제용 조성물
BRPI0516706B1 (pt)	2015-08-11	Composição inseticida e método para controle de insetos e pestes
JP5451601B2 (ja)	2014-03-26	安定な非水性ポアオン組成物
EP1244359B1 (en)	2005-01-12	Combination of fluazuron and ivermectin for parasite control
EP0836851A1 (en)	1998-04-22	Amidine compounds for use in treating ecto or endo parasitic diseases and systemic parasite control compositions
JP2024505500A (ja)	2024-02-06	抗寄生虫化合物
HU206037B (en)	1992-08-28	Process for producing nonaqueous pharmaceutical compositions for external use
CN116964031A (zh)	2023-10-27	抗寄生虫化合物
JP2001503034A (ja)	2001-03-06	外部寄生虫による温血動物への再寄生の予防方法